The paper examines 1970 Indian publications on Leishmaniasis research, as covered in Scopus database during 2008-17, registering an annual average growth rate of 17.68%, global publication share of 12.32%, international collaborative publication share of 26.85% and qualitative citation impact averaged to 17.28 citations per paper. The top 10 most productive countries individually contributed global share from 4.13% to 22.95% with largest global publication share coming from Brazil (22.95%), followed by USA (17.78%), India (12.32%), U.K., Iran and Spain (from 7.21% to 8.20%), France. Germany, Italy and Switzerland (from 4.13% to 5.95%) during 2008-17. Together, the 10 most productive countries accounted for 95.57% share of global publication output during 2008-17. Seven of the top 10 countries scored relative citation index above the world average of 1.32: Switzerland (2.17), Italy (2.0), U.K. (1.93), France (1.86), USA (1.80), Spain (1.58) and Germany (1.43) during 2008-17. Medicine, among subjects, accounted for the highest publications share (55.43%), followed by biochemistry, genetics and molecular biology (32.94%), immunology and microbiology (31.68%), pharmacology, toxicology and pharmaceutics (20.81%), chemistry (7.77%) and agricultural and biological sciences (7.56%) during 2008-17 The top 15 most productive Indian organizations and authors together contributed 78.38% and 57.06% respectively as their share of Indian publication output and 95.86% and 52.23% respectively as their share of Indian citation output during 2008-17. Among the total journal output of 1603 papers, the top 15 journals contributed 26.17% share to the Indian journal output during 2008-17. 20 papers registered from 102 to 5725 citations per paper, which together received 211897 citations, leading to an average of 594.85 citations per paper during 2008-17.
